ClinVar Miner

Submissions for variant NM_000540.2(RYR1):c.6721C>T (rs200563280)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Baylor Genetics RCV000171129 SCV000245532 pathogenic Minicore myopathy 2013-12-23 criteria provided, single submitter clinical testing This variant has been previously reported as disease-causing and was found once in our laboratory in trans with another pathogenic variant [T4709M] in a 25-year-old female with motor delays, tinnitus, vertigo, central hypotonia, peripheral hypertonia, pes cavus, dysmorphisms, microcephaly, ophthalmoplegia, supraventricular tachycardia, scoliosis, lordosis
Biesecker Lab/Clinical Genomics Section,National Institutes of Health RCV000178453 SCV000265719 pathogenic Malignant hyperthermia, susceptibility to, 1 2013-07-01 criteria provided, single submitter research
CSER_CC_NCGL; University of Washington Medical Center RCV000148787 SCV000190525 likely benign Multi-minicore disease and atypical periodic paralysis 2014-06-01 no assertion criteria provided research
Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics RCV000147436 SCV000609573 pathogenic not provided 2017-05-19 criteria provided, single submitter clinical testing
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000147436 SCV000230536 pathogenic not provided 2015-02-19 criteria provided, single submitter clinical testing
GeneDx RCV000147436 SCV000329505 pathogenic not provided 2018-02-08 criteria provided, single submitter clinical testing The R2241X pathogenic variant in the RYR1 gene has been previously reported in both the homozygous and compound heterozygous state in multiple individuals with RYR1-related disorders (Zhou et al., 2010; McKie et al., 2014; Todd et al., 2015). Functional studies have demonstrated the R2241X variant results in nonsense mediated mRNA decay; as the allele carrying the nonsense variant was not amplified from mRNA (Zhou et al., 2010). The R2241X variant is observed in 22/10140 (0.217%) alleles from individuals of Ashkenazi Jewish background and 40/276908 total alleles in large population cohorts (Lek et al., 2016). Therefore, we interpret R2241X to be a pathogenic variant.
Genetic Services Laboratory, University of Chicago RCV000147436 SCV000194849 pathogenic not provided 2013-11-05 criteria provided, single submitter clinical testing
Invitae RCV000525302 SCV000660005 pathogenic RYR1-Related Disorders 2018-10-30 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg2241*) in the RYR1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs200563280, ExAC 0.03%). This variant has been reported in the compound heterozygous state in multiple individuals affected with autosomal recessive congenital myopathy (PMID: 24951453, 20080402, 24195946, 23553787, 22473935). ClinVar contains an entry for this variant (Variation ID: 159856, 224660). Loss-of-function variants in RYR1 are known to cause autosomal recessive RYR1-related disorders (PMID: 23919265, 20583297). For these reasons, this variant has been classified as Pathogenic.
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000263175 SCV000711660 pathogenic Myopathy, Central Core; Neuromuscular Diseases 2016-04-10 criteria provided, single submitter clinical testing The p.Arg2241X variant in RYR1 has been reported in at least 4 individuals with myopathy in the compound heterozygous state (Illingworth 2014, Zhou 2010, Klein 2012) and in several homozygous affected members of one family with foetal akine sia deformation sequence/lethal multiple pterygium syndrome (McKie 2014). This n onsense variant leads to a premature termination codon at position 2241, which i s predicted to lead to a truncated or absent protein. Loss of function in the RY R1 gene is associated with myopathies including central core disease, multi-mini core disease, centronuclear myopathy, and congenital fiber type disproportion. This variant was also identified in 20/120,468 chromosomes by the Exome Aggregat ion Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs200563280) though its frequency is low enough to be consistent with a recessive carrier frequency. In summary, this variant meets our criteria to be classified as pathogenic for RYR1-related myopathy in an autosomal recessive manner based upon its co-occurre nce in trans with other pathogenic variants in patients, low frequency in contro ls and its predicted functional impact.
OMIM RCV000171129 SCV000223695 pathogenic Minicore myopathy 2014-12-05 no assertion criteria provided literature only
PreventionGenetics RCV000147436 SCV000852727 pathogenic not provided 2016-06-01 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.